Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F7VD6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,913
Award facts
- Contract value 100% obligated
- $73,912.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,912.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, utilizes firm fixed-price pricing and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with the work to be performed at its corporate office location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Repatha (evolocumab) is a PCSK9 inhibitor indicated for the treatment of high cholesterol and cardiovascular disease risk reduction in military healthcare beneficiaries and veterans. The SureClick auto-injector formulation provides patients with a convenient, pre-filled delivery mechanism for this specialty pharmaceutical. AmerisourceBergen's substantial IDC with DLA Troop Support Medical, coupled with its demonstrated capability to competitively compete for and fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains, positions the company as a critical vendor within the Department of Defense medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F7VD6?
SPE2DR26F7VD6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F7VD6 worth?
The government has obligated $73,913 on SPE2DR26F7VD6.
Is contract SPE2DR26F7VD6 an order under another contract?
Yes. SPE2DR26F7VD6 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VD6 competed?
The extent of competition for SPE2DR26F7VD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award